Veterinary Clostridium Vaccine Market

Global Veterinary Clostridium Vaccine Market is valued at USD 563.3 Million in 2021 and is expected to reach USD 798.3 Million by 2028 with a CAGR of 5.1% over the forecast period.

Global Veterinary Clostridium Vaccine Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2022-2028- Increasing prevalence of clostridium diseases, rising consumption of animal meat, and growing awareness for animal health are major factors anticipated to drive the growth of Global Veterinary Clostridium Vaccines Market.

Scope of Veterinary Clostridium Vaccine

The veterinary clostridium vaccines are used to protect against clostridial diseases in animals. The veterinary clostridium vaccines are available in variety of combinations that consist of bacterins, toxoids, or mixtures of bacterins and toxoids. The clostridium vaccine includes two doses of vaccines single vaccination with most clostridial vaccines does not provide adequate levels of protection and must be followed by a booster dose within 3–6 weeks. The clostridium vaccinations mostly given to pregnant animals for maximum immunity is transferred to the baby animals via colostrums as vaccination of young animals does not produce adequate defensive immunity awaiting they are at least 1–2 months old. The Clostridial vaccines are mostly used in farming countries where farming of cattle, sheep, goats and horses occurs on a commercial scale. The clostridium infection cause number of diseases syndromes in animals such as blackleg, pulpy kidney, braxy, tetanus and black disease.

The Covid-19 pandemic has also impacted the growth of global veterinary clostridium vaccine market. During a pandemic, there is the unavailability of raw material for manufacturing animal vaccines due to restrictions on transportation and lack of labours also created a gap between the supply chains. Also, the entire focus of the healthcare industry was shifted on Covid-19 vaccine development. Hence, global veterinary clostridium vaccine market has affected during Covid-19 pandemic.

Key Players of Veterinary Clostridium Vaccine Market

Some of the key players for the global veterinary clostridium vaccine market are

• Bimeda, Inc
• Ceva
• Eli Lilly and Company
• Intervet Inc.
• Virbac
• Zoetis, Inc.
• Aratana Therapeutics, Inc.
• ARKO Labs
• CanFel Therapeutics
• CEVA Logistics
• Bayer AG
• Hygieia Biological Laboratories
• Nuovo Biologics, LLC
• Boehringer Ingelheim International GmbH
• Sanofi 
• others.

Veterinary Clostridium Vaccine Market Segmentation

The global veterinary clostridium vaccine market is segmented on the basis of animal, distribution channel and region & country level. On the basis of animal, the global veterinary clostridium vaccine market is segmented into bovine, ovine, swine, caprine, poultry and others. On the basis of distribution channel, the global veterinary clostridium vaccine market is segmented into the veterinary hospital, veterinary clinic, veterinary research institutes and retail pharmacies.

By Animal:

• Bovine
• Ovine
• Swine
• Caprine
• Poultry
• Others

By Distribution Channel:

• Veterinary Hospital
• Veterinary Clinic
• Veterinary Research Institute
• Retail Pharmacy

The regions covered in the global veterinary clostridium vaccine market report are North America, Europe, Asia-Pacific, Latin America and Rest of the World. On the basis of country level, the market of global veterinary clostridium vaccine is sub-divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, India, Japan, South East Asia, Middle East Asia (UAE, Egypt, Saudi Arabia) GCC, Africa, etc.

Increasing Prevalence of Clostridium Diseases, Rising Demand of Animal Meat and Growing Awareness regarding the Animal Health are Major Factors Driving the Market Growth

One of the major factors driving the growth of the global veterinary clostridium vaccines market is increasing prevalence of clostridium diseases. Rising number of livestock animals will increase the demand of veterinary clostridium vaccines. These vaccines are very effective against clostridium diseases and increasing number of these animals will directly increase the market of veterinary clostridium vaccines for the forecast period. For instance; according to global distribution of livestock animals, there have been 43 billion cattle, 1.87 billion sheep and goats, 0.98 billion pigs, and 19.60 billion chickens. In addition, another factor driving the growth of the global veterinary clostridium vaccine market is rising demand of animal meat. The demand of meat is increasing day by day for the health conscious people as the animal meat contain high protein content. For example, according to the Organization for Economic Co-operation Development (OECD) and the Food and Agricultural Organization (FAO) of the United Nations Agricultural Outlook 2021-2030, the global meat consumption per capita is anticipated to increase 0.3% p.a. to 35.4 kg by 2030.

Moreover, growing awareness regarding animal health is also fostering market growth. The government is continuously focused on improving animal health as the majority of agri-food products, and livestock farming is maintained as healthy animals produce more milk, meat, eggs, and have less sickness and lower mortality thus different initiatives programs by the government drives the growth of the global veterinary clostridium vaccine market. For example; the government launched the Livestock Health & Disease Control scheme system by which they improve by implementing of prophylactic vaccination programs against various diseases of livestock and poultry and different disease surveillance is for improving veterinary infrastructure.

However, high maintenance cost of veterinary clostridium vaccines is expected to restrain the growth of the veterinary clostridium vaccines market. In spite of that, research and developments in veterinary clostridium vaccines can provide more opportunities for the further growth of the global veterinary clostridium vaccines market.

North America is Expected to Dominate the Global Veterinary Clostridium Vaccines Market

North America is expected to dominate the global veterinary clostridium vaccines market due to the increasing prevalence of clostridium diseases, rising consumption of animal-based food products and growing number of veterinary centers in this region. The increasing prevalence of veterinary clostridium diseases drives the veterinary clostridium vaccines market in North America region. In addition to that, rising consumption of animal-based food products and growing number of veterinary centers for animal health care which include the animal clostridium vaccinations also driving the market growth. For animal-based food products, animal hygiene is maintained by vaccinating the animal. For instance; according to PETA, each year millions of pigs killed every year for food.

Asia Pacific is the fastest-growing region in the global veterinary clostridium vaccine market due to the increasing veterinary centers, rising number of livestock animals and improving healthcare industry in this region. For instance; according to Animal Health India India’s livestock wealth includes 192.48 million cattle, 109.85 million and buffaloes, 148.88 million goats, 74.26 million sheep and 9.06 million pigs. India is the largest producer of milk globally with production of 187.74 million. Thus, animal health care in India drives the market growth of global veterinary vaccines market. For example; as per World Organization for Animal Health, there are presently around 31, 363 Veterinary Institutes in India These veterinary institutes will increase the market of the global veterinary clostridium vaccines market by providing vaccination awareness and vaccination programmes for animals.

On Special Requirement Veterinary Clostridium Vaccine Market Report is also available for below Regions and Country:

North America

• U.S.
• Canada

Europe

• Germany
• France
• U.K.
• Italy
• Spain
• Sweden
• Netherland
• Turkey
• Switzerland
• Belgium
• Rest of Europe

Asia-Pacific

• South Korea
• Japan
• China
• India
• Australia
• Philippines
• Singapore
• Malaysia
• Thailand
• Indonesia
• Rest Of APAC

Latin America

• Mexico
• Colombia
• Brazil
• Argentina
• Peru
• Rest of South America

Middle East and Africa

• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest Of MEA

Report Analysis	Details
Historical data	2015 - 2020
Forecast Period	2021 - 2028
Market Size in 2021:	USD 563.3 Million
Base year considered	2020
Forecast Period CAGR %:	5.1%
Market Size Expected in 2028:	USD 798.3 Million
Tables, Charts & Figures:	175
Pages	200
veterinary clostridium vaccine manufacturers	Bimeda, Inc, Ceva, Eli Lilly and Company, Intervet Inc., Virbac, Zoetis, Inc., Aratana Therapeutics, Inc., ARKO Labs, CanFel Therapeutics, CEVA Logistics, Bayer AG, Hygieia Biological Laboratories, Nuovo Biologics, LLC, Boehringer Ingelheim International GmbH, Sanofi and others.
Segments Covered	By Animal, By Distribution Channel
Regional Analysis	North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa

Key Benefits of Global Veterinary Clostridium Vaccine Market Report-

• Global Veterinary Clostridium Vaccine Market report covers in-depth historical and forecast analysis.
• Global Veterinary Clostridium Vaccine Market research report provides detailed information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market Opportunities, Competitive Analysis, Regional and Country Level.
• Global Veterinary Clostridium Vaccine Market report helps to identify opportunities in the marketplace.
• Global Veterinary Clostridium Vaccine Market report covers extensive analysis of emerging trends and competitive landscape.